BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 23062185)

  • 21. Dysfunctional BRCA1 is only indirectly linked to multiple centrosomes.
    Hut HM; Rembacz KP; van Waarde MA; Lemstra W; van Cappellen WA; Kampinga HH; Sibon OC
    Oncogene; 2005 Nov; 24(51):7619-23. PubMed ID: 16205648
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polo-like kinases (Plks) and cancer.
    Takai N; Hamanaka R; Yoshimatsu J; Miyakawa I
    Oncogene; 2005 Jan; 24(2):287-91. PubMed ID: 15640844
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of centrosome amplification during arsenite-induced mitotic arrest in CGL-2 cells.
    Yih LH; Tseng YY; Wu YC; Lee TC
    Cancer Res; 2006 Feb; 66(4):2098-106. PubMed ID: 16489010
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intense nanosecond pulsed electric fields promote cancer cell apoptosis through centrosome-dependent pathway involving reduced level of PLK1.
    Zou H; Gan XL; Linghu LJ; Chen C; Hu LN; Zhang Y
    Eur Rev Med Pharmacol Sci; 2013 Jan; 17(2):152-60. PubMed ID: 23377802
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Centrosome abnormalities are frequently observed in non-small-cell lung cancer and are associated with aneuploidy and cyclin E overexpression.
    Koutsami MK; Tsantoulis PK; Kouloukoussa M; Apostolopoulou K; Pateras IS; Spartinou Z; Drougou A; Evangelou K; Kittas C; Bartkova J; Bartek J; Gorgoulis VG
    J Pathol; 2006 Aug; 209(4):512-21. PubMed ID: 16739112
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of griseofulvin as an inhibitor of centrosomal clustering in a phenotype-based screen.
    Rebacz B; Larsen TO; Clausen MH; Rønnest MH; Löffler H; Ho AD; Krämer A
    Cancer Res; 2007 Jul; 67(13):6342-50. PubMed ID: 17616693
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Centrosomes and associated proteins in pathogenesis and treatment of breast cancer.
    Athwal H; Kochiyanil A; Bhat V; Allan AL; Parsyan A
    Front Oncol; 2024; 14():1370565. PubMed ID: 38606093
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TTK kinase is essential for the centrosomal localization of TACC2.
    Dou Z; Ding X; Zereshki A; Zhang Y; Zhang J; Wang F; Sun J; Huang H; Yao X
    FEBS Lett; 2004 Aug; 572(1-3):51-6. PubMed ID: 15304323
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FGF-2 disrupts mitotic stability in prostate cancer through the intracellular trafficking protein CEP57.
    Cuevas R; Korzeniewski N; Tolstov Y; Hohenfellner M; Duensing S
    Cancer Res; 2013 Feb; 73(4):1400-10. PubMed ID: 23243019
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Centrosome abnormalities and genomic instability induced by human papillomavirus oncoproteins.
    Duensing S; Münger K
    Prog Cell Cycle Res; 2003; 5():383-91. PubMed ID: 14593733
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Direct evidence for the role of centrosomally localized p53 in the regulation of centrosome duplication.
    Shinmura K; Bennett RA; Tarapore P; Fukasawa K
    Oncogene; 2007 May; 26(20):2939-44. PubMed ID: 17072342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mortalin controls centrosome duplication via modulating centrosomal localization of p53.
    Ma Z; Izumi H; Kanai M; Kabuyama Y; Ahn NG; Fukasawa K
    Oncogene; 2006 Aug; 25(39):5377-90. PubMed ID: 16619038
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A tentative classification of centrosome abnormalities in cancer.
    Duensing S
    Cell Biol Int; 2005 May; 29(5):352-9. PubMed ID: 15890539
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Centrosome function in cancer: guilty or innocent?
    Zyss D; Gergely F
    Trends Cell Biol; 2009 Jul; 19(7):334-46. PubMed ID: 19570677
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Centrosomal-associated Proteins: Potential therapeutic targets for solid tumors?
    Luan Y; Li M; Zhao Y; Li Q; Wen J; Gao S; Yang Y
    Biomed Pharmacother; 2021 Dec; 144():112292. PubMed ID: 34700231
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of centrosomes in human cancer.
    Duensing S
    Methods Cell Biol; 2015; 129():51-60. PubMed ID: 26175433
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Causes and consequences of centrosome abnormalities in cancer.
    Godinho SA; Pellman D
    Philos Trans R Soc Lond B Biol Sci; 2014 Sep; 369(1650):. PubMed ID: 25047621
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Origins and consequences of centrosome aberrations in human cancers.
    Nigg EA
    Int J Cancer; 2006 Dec; 119(12):2717-23. PubMed ID: 17016823
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A look into centrosome abnormalities in colon cancer cells, how they arise and how they might be targeted therapeutically.
    Harrison LE; Bleiler M; Giardina C
    Biochem Pharmacol; 2018 Jan; 147():1-8. PubMed ID: 29128368
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cancer: CINful centrosomes.
    Bakhoum SF; Compton DA
    Curr Biol; 2009 Aug; 19(15):R642-5. PubMed ID: 19674544
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.